Columbia Financial director granted deferred stock units
Columbia Financial, Inc. director Noel R. Holland reported routine equity compensation activity and updated holdings.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Columbia Financial, Inc. director Noel R. Holland reported routine equity compensation activity and updated holdings. The main new transaction was an acquisition of 8.7082 shares of common stock equivalents at $19.57 per share through a stock-based deferral plan. These phantom stock units are held in a rabbi trust and will be settled in shares of stock upon distribution to Holland. Following this grant, his indirect holdings in the stock-based deferral plan increased to 10,048.6858 shares, alongside other indirect retirement-plan holdings and direct common stock. He also continues to hold fully vested stock options with an exercise price of $15.60 per share expiring in 2029.
Insights
Routine deferred stock award with updated option holdings.
Director Noel R. Holland received 8.7082 phantom stock units of Columbia Financial, Inc. at $19.57 per share through a stock-based deferral plan. This is coded as an acquisition (A), reflecting compensation rather than an open‑market trade.
The phantom stock resides in a rabbi trust under a non-qualified stock-based deferral plan and will be settled in shares upon distribution. Holland also reports fully vested stock options with a $15.60 exercise price on 83,294 underlying shares expiring in 2029, indicating a sizeable remaining derivative position.
The filing shows indirect and direct ownership lines, including retirement-plan and stock award holdings, without any reported open‑market buying or selling. Overall, this looks like standard director compensation and position reporting, with neutral implications for investors.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 8.7082 | $19.57 | $170.42 |
| holding | Stock Options (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Represents phantom stock purchased, on a non-discretionary basis, by the trustee of the Bank's rabbi trust maintained in connection with the Columbia Bank Stock Based Deferral Plan, a non-qualified stock-based deferral plan. Stock unit interests under the Columbia Bank Stock Based Deferral Plan will be settled in shares of stock upon distribution to the reporting person.
- F2. Stock Awards granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan which vest in one year on March 12, 2027.
- F3. Stock Options granted pursuant to the Columbia Financial, Inc. 2019 Equity Incentive Plan are fully vested and exercisable.
Key Figures
Key Terms
phantom stock financial
rabbi trust financial
non-qualified stock-based deferral plan financial
Stock Options (right to buy) financial
2019 Equity Incentive Plan financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Noel R. Holland report in this Columbia Financial (CLBK) Form 4?
How many deferred stock units did Noel R. Holland hold in Columbia Financial after the grant?
Were there any open-market buys or sells by Noel R. Holland in Columbia Financial stock?
What stock options does Noel R. Holland hold in Columbia Financial, Inc.?
How are the phantom stock units for Columbia Financial structured in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.